PBLS
Parabilis Medicines, Inc.
Parabilis Medicines, Inc. (PBLS) has 8 SEC Form 4 filings (29 transaction rows) in the rolling window, disclosed by 3 distinct insiders. Most recent filing: Jul 22, 2026.
The most active filer is Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. with 4 filings. Insiders have net bought $441.4M over the trailing 6 months. The largest single insider purchase in this window was $423.8M by Director, 10% Owner RA CAPITAL MANAGEMENT, L.P. on Jun 11, 2026.
- Industry:Biotechnology
- CEO:Mathai Mammen
- Employees:145
- HQ:Cambridge, MA, US
- IPO:2026-06-10
Insider Buying
$441.4M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
3
in the rolling window
| Source | ||||||
|---|---|---|---|---|---|---|
| Director, 10% Owner | Purchase | 131,420 | $3.6M | Jul 22 | SEC ↗ | |
| Director, 10% Owner | Purchase | 65,923 | $1.9M | Jul 22 | SEC ↗ | |
| Director, 10% Owner | Purchase | 47,250 | $1.4M | Jul 22 | SEC ↗ | |
Levy GuyFirst filing | 10% Owner | Purchase | 500,000 | $10.0M | Jun 29 | SEC ↗ |
| Director | Purchase | 8,435 | $233K | Jun 16 | SEC ↗ | |
| Director | Purchase | 9,065 | $240K | Jun 16 | SEC ↗ | |
| Director, 10% Owner | Purchase | 21,188,750 | $423.8M | Jun 15 | SEC ↗ | |
SEBULSKY ALANFirst filing | Director | Purchase | 12,500 | $250K | Jun 15 | SEC ↗ |
Related companies
Parabilis Medicines, Inc. is in the Healthcare sector.